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*Leishmania* parasites cause a variety of infectious diseases from cutaneous to visceral, in many developing countries around the world ([@B1]). *Leishmania* species are transmitted to their vertebrate hosts by infected sand fly bites. They have acquired means to manipulate the immune system of their hosts during their long co-evolutionary existence. Moreover, compounds attributed to the sand fly vector have been recognized to have active roles throughout the infection ([@B2], [@B3]). Among them are biomolecules found in the vectors' saliva composed of anticlotting, antiplatelet, and vasodilatory proteins and reagents. Such compounds are injected into the blood-feeding sites during transmission as well as during noninfectious feedings ([@B2], [@B4]). The existing proteins in saliva of the sand fly vectors are shown to shift the adaptive immune response from a Th1 to a Th2 cell-mediated immune response by increasing the production of IL-4 and IL-6 cytokines as well as by inhibiting the secretion of TNFα, IL-γ, IL-12 cytokines and nitric oxide by the effector cells ([@B5]).

Here, we used a partial segment (79% of an intron-less coding gene) of salivary gland protein 42 (PpSPP42) of *Phlebotomus papatasi*, the sand fly vector of *L. major*, one of the causative agents of cutaneous leishmaniasis (CL) in Iran. Although no known function has been reported for PpSPP42 since its identification in 2001 ([@B4]), its homolog, namely LJM11 salivary gland protein of *Lutzomyia longipalpis* (the vector of *L. brasiliensis* in the New World), has been shown to confer long-term protection against CL ([@B6]). Genomic DNA of *Ph. papatasi* sand fly trapped in Kaleibar region of East Azerbaijan (Iran) was used as a template along with the following forward and reverse primers, designed based on DNA sequences confirmed at Pasteur Institute of Iran (GenBank by accession number: KX611849.1). The forward primer (5′- ATCA[GAATTC]{.ul}CACC[ATG]{.ul}GCGGCTTACGATTCAGGAAATATTG-3′) contained an *EcoR*I (GAATTC) restriction site and a Kozak translation initiation sequence consensus (CACCATGGCG) and the reverse primer (5′ATCA[CTCGAG]{.ul}TCACATAATGTCTGTGCCAAAATTGAAG-3′) had an *Xho*I (CTCGAG) restriction site and a stop codon (TCA). These primers were used to amplify a 955- bp amplicon.

The PpSP42 amplicon was TA-cloned (InsTAclone™ PCR product cloning kit, Thermo Scientific, USA) and then was subcloned into pCDNA3.1+ (Invitrogen) eukaryotic expression vector, following double-digestion with *EcoR*I and *Xho*I restriction enzymes (Fermentas, Germany). The recombinant plasmid was transformed into competent *Escherichia coli* Top10 cells. The obtained pcPpSP42 plasmid was verified by restriction digestions ([Fig. 1](#F1){ref-type="fig"}).

![pcPpSP42 double-digested with *EcoR*I and *Xho*I (expected digested fragments: 955 bp for PpSP42 insert and 5428 bp for pcDNA3+ vector)](IJPH-48-1387-g001){#F1}

The integrity of the construct and the lack of deletions or mutations were verified by nucleotide sequencing (Gen Fanavaran Co.). Plasmid pcPpSP42 was successfully transfected into the HEK-293T cells (4×10^5^ cells/2ml medium/well) using X-tremeGENE HP DNA Transfection Reagent (Roche, Germany) and the overexpression of partial PpSP42 protein with an approximate Mw of ∼36 kDa was verified by SDS-PAGE and Western-Blotting using polyclonal anti- PpSP42 antibody, as shown in [Fig. 2](#F2){ref-type="fig"}.

![Western-blot of clear lysate of HEK-293T cell-line, transfected with pcPpSP42 construct after 72-h incubation period, detected by polyclonal murine anti-PP42 antibody](IJPH-48-1387-g002){#F2}

The identification of new antigens, capable of conferring long-lasting Th1 immune responses against the intracellular *Leishmania* parasites, may play the most essential role for prophylactic control of leishmaniasis. DNA vaccines are a promising option in this regard which can trigger Th1 cell signaling route by induction of CD4+ and CD8+ T-cells like an adjuvant ([@B7]).

The constructed eukaryotic expression vector in this study was capable of expressing SpPP42 in mammalian HEK cell line. The protective efficacy of this construct as a DNA vaccine against L. major-inflicted zoonotic CL remains will be evaluated using a murine model of the infection.
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